[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Hims House [@himshouse](/creator/twitter/himshouse) on x 26.5K followers Created: 2025-06-27 16:56:00 UTC 🚨 IF $NVO SUES $HIMS ON INTELLECTUAL PROPERTY GROUNDS, THEY EXPOSE THEIR SEMAGLUTIDE PATENTS TO THE RISK OF INVALIDATION Just last year, the FTC called Novo Nordisk's patents for Ozempic, Saxenda, and Victoza "junk patent listings". Maybe a lawsuit will come. Maybe not. If it does, it's just as risky for Novo. Likely outcome: settlement.  XXXXXX engagements  **Related Topics** [listings](/topic/listings) [ozempic](/topic/ozempic) [novo](/topic/novo) [$hims](/topic/$hims) [hims](/topic/hims) [$nvo](/topic/$nvo) [stocks healthcare](/topic/stocks-healthcare) [hims hers](/topic/hims-hers) [Post Link](https://x.com/himshouse/status/1938642481639276647)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Hims House @himshouse on x 26.5K followers
Created: 2025-06-27 16:56:00 UTC
🚨 IF $NVO SUES $HIMS ON INTELLECTUAL PROPERTY GROUNDS, THEY EXPOSE THEIR SEMAGLUTIDE PATENTS TO THE RISK OF INVALIDATION
Just last year, the FTC called Novo Nordisk's patents for Ozempic, Saxenda, and Victoza "junk patent listings".
Maybe a lawsuit will come. Maybe not.
If it does, it's just as risky for Novo.
Likely outcome: settlement.
XXXXXX engagements
Related Topics listings ozempic novo $hims hims $nvo stocks healthcare hims hers
/post/tweet::1938642481639276647